PROCEPT BioRobotics Corporation Basic Shares Outstanding (Weighted Average)
PROCEPT BioRobotics Corporation (PRCT) reported Basic Shares Outstanding (Weighted Average) of 57.07 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- PROCEPT BioRobotics Corporation weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 57.07M shares, a 2.93% increase year-over-year.
- PROCEPT BioRobotics Corporation weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 56.51M shares, a 2.90% increase year-over-year.
- PROCEPT BioRobotics Corporation weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 56.08M shares, a 4.14% increase year-over-year.
- PROCEPT BioRobotics Corporation weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 55.73M shares, a 7.14% increase year-over-year.
- PROCEPT BioRobotics Corporation weighted average number of shares outstanding, basic for fiscal 2025 was 55.54M shares, a 6.56% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation weighted average number of shares outstanding, basic for fiscal 2024 was 52.13M shares, a 10.31% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation weighted average number of shares outstanding, basic for fiscal 2023 was 47.26M shares, a 6.43% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation weighted average number of shares outstanding, basic for fiscal 2022 was 44.40M shares, a 169.42% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 57.07M shares 10-Q · filed 2026-08-05 | 56.79M shares 10-Q · filed 2026-08-05 | 56.55M shares derived: average of 3 quarters · filed 2026-08-05 | 56.35M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 56.51M shares 10-Q · filed 2026-04-30 | 56.29M shares derived: average of 2 quarters · filed 2026-04-30 | 56.11M shares derived: average of 3 quarters · filed 2026-04-30 | 55.94M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 56.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 55.90M shares derived: average of 2 quarters · filed 2026-02-26 | 55.75M shares derived: average of 3 quarters · filed 2026-08-05 | 55.54M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 55.73M shares 10-Q · filed 2025-11-05 | 55.59M shares derived: average of 2 quarters · filed 2026-08-05 | 55.37M shares 10-Q · filed 2025-11-05 | 54.98M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 55.45M shares 10-Q · filed 2026-08-05 | 55.18M shares 10-Q · filed 2026-08-05 | 54.74M shares derived: average of 3 quarters · filed 2026-08-05 | 54.06M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 54.92M shares 10-Q · filed 2026-04-30 | 54.38M shares derived: average of 2 quarters · filed 2026-04-30 | 53.59M shares derived: average of 3 quarters · filed 2026-04-30 | 53.10M shares derived: average of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | 53.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 52.93M shares derived: average of 2 quarters · filed 2026-02-26 | 52.49M shares derived: average of 3 quarters · filed 2026-02-26 | 52.13M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 52.01M shares 10-Q · filed 2025-11-05 | 51.82M shares derived: average of 2 quarters · filed 2025-11-05 | 51.55M shares 10-Q · filed 2025-11-05 | 51.32M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 51.62M shares 10-Q · filed 2025-08-07 | 51.32M shares 10-Q · filed 2025-08-07 | 51.09M shares derived: average of 3 quarters · filed 2026-02-26 | 50.39M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 51.01M shares 10-Q · filed 2025-05-02 | 50.82M shares derived: average of 2 quarters · filed 2026-02-26 | 49.98M shares derived: average of 3 quarters · filed 2026-02-26 | 48.78M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 50.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 49.47M shares derived: average of 2 quarters · filed 2026-02-26 | 48.03M shares derived: average of 3 quarters · filed 2026-02-26 | 47.26M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 48.31M shares 10-Q · filed 2024-10-28 | 46.73M shares derived: average of 2 quarters · filed 2024-10-28 | 46.13M shares 10-Q · filed 2024-10-28 | 45.83M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 45.16M shares 10-Q · filed 2024-08-02 | 45.02M shares 10-Q · filed 2024-08-02 | 45.00M shares derived: average of 3 quarters · filed 2025-02-27 | 44.91M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 45.07M shares 10-Q · filed 2024-05-02 | 44.92M shares derived: average of 2 quarters · filed 2025-02-27 | 44.83M shares derived: average of 3 quarters · filed 2025-02-27 | 44.70M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 44.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 44.71M shares derived: average of 2 quarters · filed 2025-02-27 | 44.58M shares derived: average of 3 quarters · filed 2025-02-27 | 44.40M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 44.64M shares 10-Q · filed 2023-11-02 | 44.48M shares derived: average of 2 quarters · filed 2023-11-02 | 44.28M shares 10-Q · filed 2023-11-02 | 44.16M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | 44.32M shares 10-Q · filed 2023-07-28 | 44.09M shares 10-Q · filed 2023-07-28 | 44.01M shares derived: average of 3 quarters · filed 2024-02-28 | 35.90M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | 43.85M shares 10-Q · filed 2023-05-04 | 43.85M shares derived: average of 2 quarters · filed 2024-02-28 | 33.09M shares derived: average of 3 quarters · filed 2024-02-28 | 26.22M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | 43.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 27.71M shares derived: average of 2 quarters · filed 2024-02-28 | 20.34M shares derived: average of 3 quarters · filed 2024-02-28 | 16.48M shares 10-K · filed 2024-02-28 |
| 2021-09-30 | 11.58M shares 10-Q · filed 2022-11-04 | 8.59M shares derived: average of 2 quarters · filed 2022-11-04 | 7.36M shares 10-Q · filed 2022-11-04 | 6.67M shares derived: average of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | 5.60M shares 10-Q · filed 2022-08-05 | 5.22M shares 10-Q · filed 2022-08-05 | 5.03M shares derived: average of 3 quarters · filed 2022-08-05 | 4.86M shares derived: average of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | 4.83M shares 10-Q · filed 2022-05-06 | 4.75M shares derived: average of 2 quarters · filed 2022-05-06 | 4.61M shares derived: average of 3 quarters · filed 2022-05-06 | |
| 2020-12-31 | 4.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | 4.50M shares derived: average of 2 quarters · filed 2022-03-22 | 3.66M shares 10-K · filed 2022-03-22 | |
| 2020-09-30 | 4.33M shares 10-Q · filed 2021-11-05 | 3.33M shares 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |